Kimberly Hanks

• Responsible for overseeing profit and loss by auditing daily profit reports
• Facilitated communication between departments to streamline processes.
• Analyzed sales data to identify trends and inform decision-making.
• Developed and implemented policies and procedures to improve operational efficiency.

Sales and Promotion of Heartgard, Nexgard, Vaccines and other therapeutic medications for small animals. Responsible for marketing products within key accounts by utilizing merchandise and other marketing tools. All products sold as buy and bill. Worked with veterinarians, practice managers and office staff to achieve sales goals.

Sales and Promotion of Xiaflex (injectable biologic) for Peyronie’s Disease (rare/orphan disease); Aveed and Testopel for testosterone replacement therapy, and Edex (injectible) for erectile dysfunction. Responsibilities include working with urology accounts to identity appropriate patients, working with specialty pharmacies, buy and bill, utilizing a HUB service, collaborating with Field Reimbursement Managers, REMS and injection procedure training for healthcare facilities and healthcare providers.

Sales and promotion of Namenda and product launch Namenda XR and Namzeric for the treatment of Moderate to Severe Alzheimer's Disease. Sales and promotion of Bystolic for the treatment of Hypertension. Sales and Promotion of Lexapro for the treatment of Major Depressive Disorder and Generalized Anxiety Disorder. Sales and Promotion of Viibryd and product launch of Fetzima for the treatment of Major Depressive Disorder. Sales and promotion of Linzess for the treatment of Chronic Idiopathic Constipation and Irritable Bowel Disease. Product launch of Tudorza Pressair and Daliresp for the treatment of Chronic Obstructive Pulmonary Disease. Called on Cardiologist, Nephrologist, Gastroenterologist, Pulmonologist, Psychiatrist, Neurologist, Endocrinologist, Primary Care, Internal Medicine, and Family Practice physicians.

Sales and Promotion of Oxycontin, Hysingla ER, and Butrans Transdermal Patch for the treatment of chronic pain. Product launch of Symproic for Opioid Induced Constipation in top 10%. Responsible for growing market share and opioid risk education with Pain Management, Anesthesiologist, Neurologist, and Internal Medicine physicians. Called on Long Term Care Facilities, Military Accounts, and Closed Provider pharmacies. Ranked top 10% for 2016, 2017, and 2018 YTD. Served as District Field Trainer for 2017.